Cholesterol lowering
action: Numerous studies have shown the antihypercholesterolemic action of
plant sterols and stanols in normo- and hypercholesterolemic subjects.
One study on 15 hypercholesterolemic men and women received a total
dosage of 1.8 grams/day of either unesterified plant sterols (NS), plant stanols
(SS), 50:50 mixture of sterols and stanols (NSS), or cornstarch (placebo). Each
dietary treatment phase was a 21-day feeding period, followed by a 4-week
washout period in which subjects consumed their habitual diets. Although the NS
and SS group lowered plasma total cholesterol (p<0.01) and LDL cholesterol
concentrations (p< 0.03), the most significant difference was in the NSS
group, where total and LDL cholesterol concentrations were lowered by13.1%, and
16.0%, respectively. Cholesterol absorption efficiency, [measured by the
cholesterol fractional synthesis rate (FSR)] was also lower in the treatment
groups than in the control group. These results indicate that plant sterols and
stanols lower plasma total and LDL cholesterol concentrations in
hypercholesterolemic subjects by reducing cholesterol absorption.[~15~]
A study was done on subjects with normal blood cholesterol
concentrations to examine the effect of plant stanol esters on fasting
concentrations of plasma lipids and lipid-soluble antioxidants. Sixty subjects
consumed 3 cups yoghurt/day emulsified with 3 grams of plant stanol esters or
placebo yoghurt for 4 weeks. A 13.7% reduction in LDL cholesterol concentration
(p<0.001) was observed in the experimental group, and maximal effects were
observed after 1 week. These results produce the same effect as oil-based
products enriched with plant stanols/sterol esters that have shown to lower LDL
cholesterol concentrations 10-14%. Decreases in absolute beta-carotene
concentrations in all apo-B containing lipoproteins were also observed.[~16~]
According to a recent review, little difference has been observed
between Delta(5)-sterols and 5-alpha reduced stanols. It was suggested that 2
grams/day of plant sterol or stanol esters lower LDL cholesterol concentrations
by 10%. Current research on plant sterols and stanols also suggest that
phytosterols are safe when added to a varied diet. [~17~]
Preliminary
data suggest that there is a greater risk reduction in coronary artery disease
in patients achieving lower blood LDL cholesterol concentrations. Although plant
stanols/sterols cannot replace statin medications for the aggressive treatment
to lower LDL cholesterol (especially in the high-risk patient), plant
sterol/stanols are considered an effective and well-tolerated lipid-lowering
therapy. Moreover, combination therapy with statin medication plus plant
stanols/sterols can be useful to achieve aggressive blood lipid concentration
goals in high-risk patients with dyslipidemia. [~18~]
American Dietetic
Association (ADA) Statement on Plant Stanol/Sterol esters ADA’s new
evidence-based guidelines for Hyperlipidemia state: 'stanol/sterol esters are
effective in lowering serum total cholesterol and LDL cholesterol by
approximately 10-15%. Consider using plant stanol/sterol products incorporating
2-3 grams of plant stanol/sterol esters per day… [~19~]
FDA Statement
on Plant Sterols/Stanols: On February 14, 2003, the FDA published the
interim final rule (IFR) authorizing the use of a health claim for plant
sterol/stanol esters and reduced risk for coronary heart disease (CHD) on food
labels. The IFR authorizes the use of a health claim relating between plant
sterol/stanol esters and reduced risk of CHD on labeling of:
- spreads and dressings for salad containing at least 0.65 grams of plant
sterol esters per serving,
- spreads, dressings for salad, snack bars, and dietary supplements in
softgel form containing at least 1.7 grams plant stanol esters per
serving. [~20~]
Effect on plasma fat-soluble
vitamin/carotenoid concentrations:
There has been conflicting evidence on the consumption of plant
sterols/stanols and their effect on plasma fat-soluble vitamin and carotenoid
concentrations:
One study compared the consumption of plant sterol/stanol
esters on serum fat-soluble vitamin and carotenoid concentrations. Fifteen
subjects were randomly fed a diet containing either margarine (control),
margarine with sterol esters (1.92 grams/day), or margarine with stanol esters
(1.76 grams/day) over 21 days. No significant differences were found in initial
or final serum concentrations of fat-soluble vitamins or carotenoids among the 3
phases. These results suggest that consumption of esterified plant sterols or
stanols does not effect fat-soluble vitamin or carotenoid concentrations when
compared to a control diet. [~21~]
Forty-six subjects with
hypercholesterolemia consumed a sterol-free spread (control), a sterol ester
spread (2.3 grams) and a stanol ester spread (2.5 grams). With each treatment,
subjects were advised to eat 5 or more servings of fruits and vegetables, and
one or more the servings was to be carrots, sweet potatoes, pumpkin, tomatoes,
apricots, spinach or broccoli. Adding 1 daily serving of vitamin A-rich fruit or
vegetable while consuming plant sterol or stanols esters, allowed subjects to
maintain normal plasma carotenoid concentrations. Thus, it is recommended for
individuals to consume an additional serving of a carotenoid-containing fruit or
vegetable when consuming plant sterol or stanol products. [~22~]
A
recent mini-review discusses how regular consumption of plant sterols/stanols
may result in a 10-20% decrease in plasma carotenoid concentrations. Although it
is believed that there is no health risk associated with slight decrease in
blood concentrations of carotenoids due to intake of plant sterol/stanols, the
mechanism of how plant sterols/stanols affect plasma carotenoid concentrations
is unclear. Data on carotenoids was pooled from 2 studies on plant sterols.
Plasma carotenoid concentrations were presented as tertile values, showing that
subjects with the lowest plasma carotenoid concentrations had the least decrease
in their plasma alpha-, beta-carotene and lycopene levels. The mid and
high-tertile subjects demonstrated a higher decrease in alpha and beta-carotene
concentrations, more so than the lowest tertile group. However, the plasma
levels of carotenoids in the mid and high tertile groups did not reach the level
found in the low tertile group. The same was found for lycopene. From
this, the importance of variability in baseline carotenoid levels among subjects
was highlighted. Numerous factors affect plasma carotenoid levels (dietary
habits, vegetable/fruit intake, seasonal variation (10-40%), bioavailability of
carotenoids, etc.) [~23~]
A one-year, randomized, double-blind study was
conducted using placebo and either 1.8 or 2.6 g of sitostanol per day as
margarine. The result showed that margarine containing stanols significantly
lowered serum total and LDL cholesterol concentrations compared to placebo.
Although no difference was found for the first 6 months between the 1.8 g and
2.6 g sitostanol groups, higher amounts of sitostanol in margarine (2.6 g)
showed slightly but significantly greater decrease between 6 and 12 months of
study. 8
A double-blind study with 55 hypercholesterolemic subjects
for 8 weeks was conducted to see if plant stanols decrease serum cholesterol
concentrations using two different sources of stanols. Plant stanols were
derived from soy oil or wood. The stanol composition in wood and vegetable oil
was 2.15 g and 0.19 or 1.50 g and .07 g of sitostanol and campestanol,
respectively. The basic diet was low fat (25 – 26% of energy) during the
experiment. The reduction in serum total cholesterol concentrations was 10.6%
and 8.1% greater than in the control group. The same trend was observed on serum
LDL cholesterol concentrations. Results suggested that plant stanol esters with
a low fat diet can diminish serum cholesterol concentrations. 9
In
one study with healthy or mildly hypercholesterolemic subjects, three different
levels of plant sterol margarine spreads were given to see the effect on blood
lipid and fat-soluble nutrients. Plant sterols at the level of 0.83, 1.61 and
3.24 g/day or placebo were fed for 3.5 weeks. Compared to the control spreads,
total serum cholesterol concentration significantly decreased by 0.26 – 0.35
mmol/L for the 3 plant sterol groups. However, there was no difference of
cholsterol-lowering action among sterol groups. Lipid standardized carotene
concentrations were decreased by 0.83 and 3.24 g plant sterols. The author
concluded that daily ingestion of 1.6 g plant sterols may favorably influence
serum cholesterol concentrations. 10
In a review paper, Law found
the reduction of serum LDL cholesterol concentration was significantly greater
in old people than in young people. Plant sterols or stanols decreased serum LDL
cholesterol concentrations in a dose-dependent manner up to 2 g/day. 11
Prostate Cancer: An animal study was done to examine the effect
of phytosterols (PS) versus cholesterol on the growth and metastasis of the PC-3
human prostate cancer cells in SCID mice. The SCID mice were fed a diet
containing 2% of either a PS mixture or cholesterol plus 0.2% cholic acid, and
implanted with 2x10(6) tumour cells per mouse. The experimental diet consisted
of 39.7% cornstarch, 20% casein, 13.2% maltodextrin, 10% sucrose, 7% soybean
oil, 5% cellulose, 3.5% mineral mix, 1% vitamin mix, 0.3% L-cystine, 0.25%
choline bitartrate and 0.0014% t-butylhydroquinone. Diets were supplemented with
0.2% cholic acid plus 2% of either cholesterol (control diet) or PS mixture.
Tumour growth was monitored for 8 weeks post inoculation, and animals fed the PS
diet had tumours 40-43% smaller than those fed the cholesterol diet. The number
of mice with lymph node and lung metastasis was almost one-half that of
cholesterol-fed group. In addition, an analysis of the growth and migration of
these cancer cells in vitro was conducted. Results found that both
beta-sitosterol and campesterol inhibited the growth of PC-3 cells by 70 % and
14%, respectively, while cholesterol supplementation increased growth by 18%
when compared with controls. PS taken as a dietary supplement can indirectly
inhibit the growth and metastasis of PC-3 cells, and PS directly (in tissue
culture media) inhibited the growth and metastasis of PC-3 cells. [~24~]
In a randomized, double-blind, placebo-controlled multicenter study, 200
subjects with symptomatic benign prostatic hyperplasia were given 20 mg
b-sitosterol three times a day for 6 months. Treatment with plant sterol
significantly lowered modified Boyarsky scores as compared to the placebo group.
The peak of urine flow was improved while mean residual urinary volume
decreased. Prostatic volume was not influenced in either group.12
Stomach Cancer: An epidemiological study in Uruguay showed there
was a strong inverse relationship between total phytosterol intake and stomach
cancer in a dose response effect. This risk of association remained similar
after adjustment for vegetables, fruits and other nutrients. Furthermore, when
combined, b-sitosterol and a-carotene showed stronger inverse association with
risk of stomach cancer. A similar inverse relationship was epidemiologically
observed in lung cancer.13 14
|